Optaflexx And Rumensin And Tylan is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2014. All patents have expired. Details of Optaflexx And Rumensin And Tylan’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5631298 | Active | |
About Optaflexx And Rumensin And Tylan
Optaflexx And Rumensin And Tylan is a drug
owned by ELANCO US INC.
Optaflexx And Rumensin And Tylan uses
Monensin, Ractopamine Hydrochloride, Tylosin Phosphate as the active
ingredients.
Active Ingredient:
Optaflexx And Rumensin And Tylan uses
Monensin,
Ractopamine Hydrochloride, Tylosin Phosphate
as the active ingredients.
Check out other Drugs and Companies using
Monensin, Ractopamine Hydrochloride, Tylosin Phosphate ingredient.